Latest Biotech News

FDA paused trials of Regenxbio’s AAV gene therapy for Hunter syndrome again after additional spine MRI findings raised new safety questions, according to statements reported by STAT+ and the...

Moderna and Merck reported positive Phase III results for their individualized neoantigen mRNA therapy, intismeran autogene (INT), in the INTerpath-001 trial, saying the treatment improved...

Roche moved to deepen its obesity pipeline by paying up to $2.3 billion to license Hanmi Pharm’s early-stage muscle-building asset targeting obesity, according to deal reporting that specifies a...

A multidisciplinary Delphi panel published in the Journal of Perinatology outlined consensus criteria for enhanced recovery pathways in newborns and infants, expanding the framework long used in...

Abcuro raised $66 million to restart development of a biologics program targeting inclusion body myositis, a rare inflammatory disorder with no approved drugs, the company said. The funding is...

Cityblock Health announced an acquisition of rural provider Homeward Health and secured $116 million in a Series E round to scale its value-based care model into rural and Medicare Advantage...

Investors responded to Moderna and Merck’s melanoma mRNA vaccine Phase III results not just in the developers’ stocks but also across sequencing companies tied to personalized oncology workflows,...

Researchers at the University of Michigan Engineering reported preclinical results for a yeast-based universal influenza vaccine candidate designed to target a conserved influenza protein. The...

A new AI-driven analysis pinpointed a DNA sequence signature that helps initiate gene expression in about 60% of human genes, according to reporting on the model’s findings after analyzing roughly...

Health Secretary Robert F. Kennedy Jr. raised questions about CDC vaccine recommendation categories in a Federal Register request for information, targeting how the U.S. government classifies...

Moderna and Merck said positive Phase 3 data support intismeran autogene, an individualized neoantigen (INT) mRNA vaccine, in combination with Keytruda (pembrolizumab). In the randomized...

Roche moved deeper into obesity with a deal for Hanmi Pharm’s clinical-stage urocortin-2 analog. Roche agreed to an upfront payment of $190 million for the asset, adding a less-explored mechanism...

Abcuro raised $66 million to restart development in inclusion body myositis, a rare inflammatory disorder with no approved therapies. The company plans to use the capital to run a Phase 2/3 study...

Cityblock Health agreed to acquire Homeward Health and secured a $116 million Series E to expand its value-based care footprint. The transaction targets rural healthcare delivery and Medicare...

Cleveland Clinic reported that rollout of Ambient Scribes improved clinician retention and satisfaction, according to new research cited from its AI scribe deployment. The hospital highlighted...

Pharma marketers are being urged to recalibrate AI spending around “share of answer” rather than impressions as clinicians increasingly engage with generative AI tools. An interview with Stephen...

Researchers used AI to identify a DNA activation initiator sequence, reporting a model that detects the initiator in roughly 60% of human genes after analyzing about 500,000 DNA sequences. The...

An author correction in npj Parkinson’s Disease renewed attention on a machine-learning approach designed to classify people with Parkinson’s disease who are at risk of falling. The publication’s...

University of Michigan researchers reported that a yeast-derived, universal influenza vaccine candidate protected mice against multiple influenza A strains by targeting a conserved viral protein....

A multi-stakeholder consensus roadmap was published in the British Journal of Cancer to guide clinical trial design for rare childhood central nervous system tumors. The effort targets structural...